These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 23639557

  • 1. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.
    McDermott M, Hughes M, Rath T, Johnson JT, Heron DE, Kubicek GJ, Kim SW, Ferris RL, Duvvuri U, Ohr JP, Branstetter BF.
    AJNR Am J Neuroradiol; 2013 Aug; 34(8):1632-6. PubMed ID: 23639557
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K.
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
    Zhang I, Branstetter BF, Beswick DM, Maxwell JH, Gooding WE, Ferris RL.
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A.
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [Abstract] [Full Text] [Related]

  • 7. Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring.
    Beswick DM, Gooding WE, Johnson JT, Branstetter BF.
    Laryngoscope; 2012 Jul; 122(7):1512-7. PubMed ID: 22685038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.
    Kim R, Ock CY, Keam B, Kim TM, Kim JH, Paeng JC, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.
    BMC Cancer; 2016 Feb 17; 16():116. PubMed ID: 26884055
    [Abstract] [Full Text] [Related]

  • 10. Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
    Marquardt M, Anderson C, Ginader T, Parkhurst J, Pagedar N, Bayon R, Clamon G, Hoover A, Buatti J.
    Ann Otol Rhinol Laryngol; 2018 Mar 17; 127(3):185-191. PubMed ID: 29313371
    [Abstract] [Full Text] [Related]

  • 11. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M, Varoquaux AD, Combescure C, Rager O, Pusztaszeri M, Burkhardt K, Delattre BMA, Dulguerov P, Dulguerov N, Katirtzidou E, Caparrotti F, Ratib O, Zaidi H, Becker CD.
    Eur Radiol; 2018 Feb 17; 28(2):651-663. PubMed ID: 28812148
    [Abstract] [Full Text] [Related]

  • 12. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.
    Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, Fee WE, Sunwoo JB, Sirjani D, Hara W, Yao M.
    Cancer; 2013 Apr 01; 119(7):1349-56. PubMed ID: 23225544
    [Abstract] [Full Text] [Related]

  • 13. Predictive accuracy of first post-treatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma.
    Koshkareva Y, Branstetter BF, Gaughan JP, Ferris RL.
    Laryngoscope; 2014 Aug 01; 124(8):1843-7. PubMed ID: 24474646
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
    Robin P, Abgral R, Valette G, Le Roux PY, Keromnes N, Rousset J, Potard G, Palard X, Marianowski R, Salaun PY.
    Eur J Nucl Med Mol Imaging; 2015 Jan 01; 42(1):72-8. PubMed ID: 25169701
    [Abstract] [Full Text] [Related]

  • 15. PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
    Yankevich U, Hughes MA, Rath TJ, Fakhran S, Alhilahi LM, Seungwon KW, Branstetter BF.
    AJR Am J Roentgenol; 2017 Apr 01; 208(4):844-848. PubMed ID: 28177644
    [Abstract] [Full Text] [Related]

  • 16. The value of PET/CT to assess clinically negative necks.
    Ozer E, Naiboğlu B, Meacham R, Ryoo C, Agrawal A, Schuller DE.
    Eur Arch Otorhinolaryngol; 2012 Nov 01; 269(11):2411-4. PubMed ID: 22249837
    [Abstract] [Full Text] [Related]

  • 17. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
    Chen SW, Hsieh TC, Yen KY, Yang SN, Wang YC, Chien CR, Liang JA, Kao CH.
    Laryngoscope; 2014 Dec 01; 124(12):2732-8. PubMed ID: 25042474
    [Abstract] [Full Text] [Related]

  • 18. Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
    Prestwich RJ, Subesinghe M, Gilbert A, Chowdhury FU, Sen M, Scarsbrook AF.
    Clin Radiol; 2012 Oct 01; 67(10):966-75. PubMed ID: 22595082
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.
    Kim SA, Roh JL, Kim JS, Lee JH, Lee SH, Choi SH, Nam SY, Kim SY.
    Eur J Cancer; 2017 Feb 01; 72():62-70. PubMed ID: 28027517
    [Abstract] [Full Text] [Related]

  • 20. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV, Walvekar RR, Andrade RS, Daamen N, Lai SY, Argiris A, Smith RP, Heron DE, Ferris RL, Johnson JT, Branstetter BF.
    Laryngoscope; 2007 Dec 01; 117(12):2129-34. PubMed ID: 17921898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.